Answers are grounded in this paper and cite their sources.
Case PresentationA 53-year-old woman with a history of EGFR mutation-positive stage IV lung adenocarcinoma underwent scheduled surveillance imaging. The disease was stable with osimertinib for the preceding 24 months. Surveillance imaging noted new paratracheal adenopathy concerning for cancer progression. She was referred to interventional pulmonology for bronchoscopic evaluation. She provided written informed consent.
No takes yet. Share an insight, caveat, or question.
Goizueta et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: